PRMT6 and breast cancer: Considering that epithelial‐mesenchymal transition (EMT) is the main pathway involved in invasion and metastasis leading to tumor progression,[15] the levels of EMT markers were assessed to clarify the molecular role of PRMT6 in breast cancer metastasis.